22.09.2016 • NewsDede WillamsLonzaNutraceuticals

Lonza Completes InterHealth Nutraceuticals Buy

With the acquisition, CEO Richard Ridinger said Lonza “will be able to...
With the acquisition, CEO Richard Ridinger said Lonza “will be able to harness Interhealth’s proven management and branding capabilities and leverage them to a global level.”

Swiss fine chemicals producer Lonza has closed the acquisition of US-based InterHealth Nutraceuticals from Kainos Capital for a price of up to $300 million, split into an upfront payment and an earn-out payment. Lonza said the integration of the nutraceuticals producer headquartered in California, which develops, manufactures and markets proprietary value-added nutritional ingredients for use in dietary supplements, will be immediately earnings accretive, as the company’s portfolio aligns closely with its own.

The California company will become part of Lonza’s consumer care business unit, but will retain its own facilities and employees. The combination of the two businesses will allow the Swiss company to offer InterHealth’s more than 15 branded ingredients, including the new acquisition’s cornerstone ingredient, UC-II, which is said to be revolutionizing the joint-health segment.

With the acquisition, CEO Richard Ridinger said Lonza “will be able to harness Interhealth’s proven management and branding capabilities and leverage them to a global level.” He said the acquisition is a step toward the company’s goal of becoming the world’s leading and most-trusted supplier to the pharmaceutical, biotech and specialty ingredients markets.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.